All Type of News
Major pharmaceutical firms set eyes on overseas market
The nation's leading pharmaceutical companies are going all-out to make inroads into foreign countries as the domestic drug market shows clear signs of reaching saturation point.
Korean drug makers demonstrate vari...
Positive list system discourages new drug development projects
Domestic pharmaceutical companies are in dilemma to cope with the current drug pricing system, called a positive list system, according to a top official of a domestic pharmaceutical firm.
In an information session...
Celebrex can be used in aspirin patients, Pfizer Korea says
Pfizer Korea says its Celebrex (celecoxib) capsule can be used with low dose of aspirin unlike other nonsteriodal anti-inflammatory drugs (NSAIDs).
Last March, the Korea Food and Drug Administration instructed manu...
Daewoong rekindling strategic alliance flame
Daewoong Pharm is actively seeking strategic alliances with a number of multinational pharmaceutical firms using its strong sales and marketing force.
Daewoong and MSD Korea have recently agreed to jointly market J...
Abbott Korea launches XIENCE V stent
Abbott Korea says it has launched its XIENCE V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of XIEN...
Korea needs speedy mergers of several research centers among major drug makers
Large domestic pharmaceutical companies should focus on research and development (R&D) of new drugs in a form to create a new research center merging several research laboratories, according to pharmaceutical observer...
BMS Korea is in dilemma over price of new leukemia drug
BMS Korea is reportedly in internal discussion over the Ministry for Health, Welfare and Family Affair committee's decision on the price of Sprycel, a new drug for the disease.
On May 7, the committee decided to fi...
Civic group hits government agency for protecting sales secret
A civic group says it filed a lawsuit against the Health Insurance Review Agency on May 8 for abusing their authority by publicly protecting medical institutions' management and sales secrets.
The Citizens' Coaliti...
KIT, Bio21 Center to set up environmental toxicology institute in 2011
State-funded Korea Institute of Toxicology (KIT) and Bio21 Center have recently agreed to establish a new environmental toxicology institute in Jinju City of South Kyungsang Province by 2011 as part of efforts to cond...
Healthcare business to drive up Choong-wae
If ethical management topped SK's growth strategy for the past years, the fresh aim of Choong-wae Pharm this year is to solidify its position in the domestic healthcare business.
Through active promotion of its ha...
